Pacific Center for Financial Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.46K | Hold |
52
| – | – | ﹤0.01% | 321 |
|
2025
Q1 | $8.92K | Hold |
52
| – | – | ﹤0.01% | 312 |
|
2024
Q4 | $8.71K | Hold |
52
| – | – | ﹤0.01% | 321 |
|
2024
Q3 | $8.95K | Hold |
52
| – | – | ﹤0.01% | 313 |
|
2024
Q2 | $8.01K | Hold |
52
| – | – | ﹤0.01% | 314 |
|
2024
Q1 | $8K | Hold |
52
| – | – | ﹤0.01% | 323 |
|
2023
Q4 | $8.23K | Hold |
52
| – | – | ﹤0.01% | 290 |
|
2023
Q3 | $7.62K | Hold |
52
| – | – | ﹤0.01% | 307 |
|
2023
Q2 | $7.97K | Hold |
52
| – | – | ﹤0.01% | 297 |
|
2023
Q1 | $8.07K | Buy |
+52
| New | +$8.07K | ﹤0.01% | 294 |
|
2022
Q3 | $7K | Hold |
52
| – | – | ﹤0.01% | 302 |
|
2022
Q2 | $7K | Hold |
52
| – | – | ﹤0.01% | 297 |
|
2022
Q1 | $8K | Hold |
52
| – | – | ﹤0.01% | 293 |
|
2021
Q4 | $8K | Hold |
52
| – | – | ﹤0.01% | 295 |
|
2021
Q3 | $9K | Hold |
52
| – | – | ﹤0.01% | 292 |
|
2021
Q2 | $9K | Hold |
52
| – | – | ﹤0.01% | 269 |
|
2021
Q1 | $8K | Hold |
52
| – | – | ﹤0.01% | 259 |
|
2020
Q4 | $9K | Hold |
52
| – | – | ﹤0.01% | 250 |
|
2020
Q3 | $8K | Hold |
52
| – | – | ﹤0.01% | 225 |
|
2020
Q2 | $9K | Hold |
52
| – | – | ﹤0.01% | 203 |
|
2020
Q1 | $7K | Hold |
52
| – | – | ﹤0.01% | 205 |
|
2019
Q4 | $8K | Hold |
52
| – | – | ﹤0.01% | 224 |
|
2019
Q3 | $6K | Hold |
52
| – | – | ﹤0.01% | 242 |
|
2019
Q2 | $7K | Hold |
52
| – | – | ﹤0.01% | 234 |
|
2019
Q1 | $8K | Hold |
52
| – | – | ﹤0.01% | 228 |
|
2018
Q4 | $6K | Hold |
52
| – | – | ﹤0.01% | 241 |
|
2018
Q3 | $8K | Hold |
52
| – | – | ﹤0.01% | 230 |
|
2018
Q2 | $7K | Hold |
52
| – | – | ﹤0.01% | 223 |
|
2018
Q1 | $7K | Hold |
52
| – | – | ﹤0.01% | 222 |
|
2017
Q4 | $6K | Hold |
52
| – | – | ﹤0.01% | 230 |
|
2017
Q3 | $6K | Hold |
52
| – | – | ﹤0.01% | 232 |
|
2017
Q2 | $6K | Hold |
52
| – | – | ﹤0.01% | 226 |
|
2017
Q1 | $5K | Hold |
52
| – | – | ﹤0.01% | 226 |
|
2016
Q4 | $5K | Buy |
+52
| New | +$5K | ﹤0.01% | 235 |
|